H Partners Obtains Clear Referendum for Change at Harley-Davidson's 2025 Annual Meeting
'We thank our fellow shareholders and all other stakeholders, including dealers, riders, and employees, for their outpouring of support during this campaign for change at Harley. While we are disappointed with the state of the Company under the leadership of Mr. Zeitz, Mr. Linebarger, and Ms. Levinson, we believe that this shareholder mandate can create a brighter future for Harley-Davidson.
We are encouraged that this campaign compelled Harley's Board to commit to numerous shareholders that Mr. Zeitz, Mr. Linebarger, and Ms. Levinson will resign from the Board before the 2026 Annual Meeting, that it will appoint a new, external CEO, and that it will eliminate any consideration of Mr. Zeitz remaining on in an Executive Chair role. With such a large withhold vote, we call on the Board to follow through on these promises.
We believe the outcome of today's Annual Meeting sends a clear message that the direction of the Company needs to change. We are pleased that our campaign forced the Board to engage directly with stakeholders that they had long ignored, including dealers, employees, and shareholders. We encourage all stakeholders to continue to voice their perspectives on what is required to fix this great company.'
H Partners Management, LLC is an independent investment firm founded in 2005 based in New York City.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
15 minutes ago
- Business Insider
UnitedHealth Stock Collapse Continues: Here's What This Investor Thinks Will Happen Next
UnitedHealth (NYSE:UNH) is coming off another bruising week, with shares down 7% – bringing the 12-month decline to a steep 50% – as a string of PR crises continues to weigh heavily on investor sentiment. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Since the assassination of Brian Thompson, the CEO of its insurance division, in New York last year, the company has faced mounting scrutiny. Investors are increasingly uneasy about UnitedHealth's transparency, while the public has raised sharp concerns over its claims-handling practices. Given the reputational setbacks, investor A.J. Button believes the fallout could soon weigh on the company's bottom line. 'Bad PR can lead to brand damage,' he warns, 'which in turn can lead to policyholders taking their business elsewhere.' That said, Button acknowledges that the company's fundamentals remain relatively strong. UNH still boasts a robust balance sheet and solid profitability metrics, suggesting it has the financial strength to withstand pressure. 'Nevertheless,' Button cautions, 'the issues facing UnitedHealth right now are very real.' One of the most pressing red flags is the company's exceptionally high claim denial rate, reportedly the highest in the sector, according to multiple sources. While not catastrophic in itself, such a pattern could indicate flawed underwriting or strained claims infrastructure – issues that compound the reputational damage and hint at possible internal mismanagement. 'So,' Button adds, 'UnitedHealth has many qualities, good and bad.' On one hand, its financial footing and history of profitability provide a cushion. On the other, cracks are beginning to show: for fiscal 2024, its combined ratio hit 97.2% – right up against the industry's red line. Button argues that, before investors can have full confidence, the company needs to take meaningful action to shore up its underwriting performance. Whether that turnaround is underway remains an open question. UnitedHealth recently reinstated former CEO Stephen Helmsley, following the previous leader's departure. But the move has raised eyebrows, given that Helmsley is a longtime insider who presided over many of the company's earlier challenges. His return doesn't exactly scream transformation. A rebound is still possible – especially if the company takes decisive steps to restore trust and address internal inefficiencies. However, given the scale of its current controversies, Button advises investors to weigh the risks carefully. Even the stock's seemingly low P/E ratio doesn't present a compelling bargain relative to peers in the life and health insurance space. 'When considering a stock like UnitedHealth, with a good track record but an unprecedented new set of risk factors, it pays to be cautious,' the investor summed up. Can UnitedHealth Stock Bounce Back? Button assigns a 'low-conviction' buy rating on UNH shares – a nod to its potential, but with more than a few strings attached. (To watch Button's track record, click here) Wall Street, though, is a bit more upbeat. The stock holds 19 Buy recommendations, 6 Holds, and just 1 Sell, translating to a Moderate Buy consensus rating. With an average price target of $364.96, analysts are eyeing 29% upside from current levels. (See UNH stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Yahoo
33 minutes ago
- Yahoo
Why BigBear.ai Stock Skyrocketed Last Week
Key Points stock surged 23.5% over the past week despite no major news for the business. The company's share price has continued to climb thanks to excitement surrounding defense-AI investments. explosive valuation has seen explosive gains lately despite little indication the company's outlook has seen big shifts. 10 stocks we like better than › (NYSE: BBAI) stock closed out this past week's trading with another run of big gains. The software and services company's share price climbed 23.5% from the previous week's market close amid a gain of 0.6% for the S&P 500 index. valuation surged again this past week, as investors continued to place bullish bets on companies with artificial intelligence (AI) tools tailored for the defense industry. The company's share price is now up 101% over the past month and 214% over the past three months. stock continues to surge despite no major news Even in the absence of apparent meaningful developments for the business, stock has continued to rally. The company's big valuation gains appear to be primarily connected to the defense-AI investment trend that has been hot in the market. Palantir has been a top defense-AI play and reached a new valuation high in this week's trading, and stock has often seen valuation moves that correspond with pricing action for the software leader. Some investors are betting that could emerge as a Palantir-like winner as demand for AI-powered defense software continues to increase. What's next for The massive valuation run up for stock appears to be out of step with the company's recent business performance and near-term outlook. Despite demand tailwinds in the AI industry, the company's revenue increased just 5% year over year in the last quarter. Growth is expected to accelerate in the second half of the company's current fiscal year, but management's midpoint target for annual sales growth of roughly 7.5% still raises valuation concerns following recent gains for the stock. While it's possible that continued acceleration for sales growth and margin improvements will pave the way for stock to see more explosive gains above its current valuation level, huge valuation gains in the absence of major news suggest that the company is a risky investment right now. Investors will get a closer look at the business on Aug. 11, when the company publishes its next quarterly report. Should you buy stock in right now? Before you buy stock in consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Stock Skyrocketed Last Week was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
39 minutes ago
- Yahoo
Valens (VLN) Powers First MIPI A-PHY Embedded Vision System
Valens Semiconductor Ltd. (NYSE:VLN) is one of the 11 Best Semiconductor Penny Stocks to Buy According to Hedge Funds. On July 15, Valens Semiconductor Ltd. (NYSE:VLN) reported that its VA7000 chipsets are now being used in D3 Embedded's MIPI A-PHY platform for embedded vision. These VA7000 chipsets by Valens Semiconductor Ltd. (NYSE:VLN) are the main connectivity solution for a comprehensive camera-to-processor MIPI A-PHY platform. This platform is the first product-ready solution in the market that brings the advanced A-PHY connectivity standard to embedded vision systems. A close-up of a digital circuit board with chips illuminated by LED lights. The A-PHY platform offers several advantages for D3's customers, such as strong resistance to electromagnetic interference (EMI), longer link distances, and operation with basic, low-cost cables. The MIPI A-PHY standard ensures excellent Electromagnetic Compatibility (EMC) performance, which means reliable data transmission even in industrial settings with electrical noise. Chipsets based on A-PHY technology support high-speed data transmission over cables as long as 30 meters or more without losing signal quality. Additionally, these chips allow for multi-gigabit connectivity through both Unshielded Twisted Pair (UTP) and micro-coaxial cables. This helps system designers to balance cost, weight, and mechanical requirements as per their specific application needs. These chipsets also provide built-in diagnostics for link monitoring and preventive maintenance so that systems can run around the clock. According to the report by Valens Semiconductor Ltd. (NYSE:VLN), these features make A-PHY-based chipsets a great fit for a broad range of applications, including robotics, industrial vehicles, industrial automation, and medical imaging. Valens Semiconductor Ltd. (NYSE:VLN) is an Israeli fabless manufacturing company that focuses on high-performance connectivity. The company provides semiconductor solutions to the automotive and audio-video industries. While we acknowledge the potential of VLN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
